Copeptin as a diagnostic tool in a patient with adipsia and hypernatremia Authors: Paula Condé Lamparelli Elias, Beatriz Ristow de Assunção, Antonio Carlos dos Santos, Margaret de Castro, Lucila Leico Kagohara Elias, Ayrton Custódio Moreira Published: 2026 ABSTRACT AbstractClassic adipsic vasopressin deficiency features hypotonic polyuria and absent thirst despite hypernatremia. We report a 21-year-old patient with prior resected pilocytic astrocytoma who presented dehydration and hypernatremia of 158 mEq/L (158 mmol/L) (reference range, 135-145 mEq/L [SI: 135-145 mmol/L]). He denied thirst and had no polyuria or polydipsia. Plasma and urinary osmolalities were 317 mOsm/Kg (317 mmol/Kg) (reference range, 282-295 mOsm/Kg [282-295 mmol/Kg]) and 878 mOsm/Kg (878 mmol/Kg) (reference range, 200-1200 mOsm/Kg [200-1200 mmol/Kg]), respectively. After prescribed oral water intake, serum sodium normalized and urinary volume remained normal. To assess osmoregulation, plasma copeptin and thirst visual scale were assessed during 3% saline infusion. Despite increases in serum sodium, the patient reported no change in thirst, confirming adipsia. Copeptin value was 3.2 pmol/L at the end of the saline infusion (reference range, 3.7-43.3 pmol/L) and 4.1 pmol/L during hypovolemic hypernatremia, both low-normal values considering hypernatremia, suggesting impaired osmolality-driven vasopressin secretion. This case illustrates a partial defect in osmoregulatory vasopressin release with maintained renal response and highlights the diagnostic utility of osmotic-stimulated copeptin measurement for functional characterization of vasopressin dynamics in rare adipsic disorders.Keywords: hypernatremia, adipsia, copeptin, vasopressin deficiency Introduction Plasma osmolality is tightly regulated by coordinated mechanisms involving thirst, vasopressin (AVP) secretion, and renal absorption of free water, with serum sodium as its key determinant [1-3]. Specialized osmoreceptors, located in the lamina terminalis on the anterior wall of the third ventricle, detect subtle increases in osmolality triggering AVP synthesis and secretion resulting in renal free water reabsorption and simultaneously activating thirst pathways via the organum vasculosum of the lamina terminalis and the subfornical organ to the anterior cingulate cortex and the posterior insula [2-5]. In addition to osmotic stimuli, non-osmotic factors, particularly hypovolemia, also regulate AVP secretion and thirst through baroreceptor-mediated and angiotensin II–dependent mechanisms [6], while anticipatory signals such as food intake, circadian rhythms, and hyperthermia further modulate thirst. Disruption of these osmotic control pathways results in clinically relevant water balance disorders, notably diabetes insipidus and adipsia [7]. Neurological damage to specific hypothalamic areas can result in AVP deficiency (AVP-D, formerly central diabetes insipidus), typically presenting with hypotonic polyuria, polydipsia, and preserved thirst. When injury extends to hypothalamic osmoreceptors, however, adipsia may develop. In this setting, the absence of thirst in response to aquaresis leads to inadequate water intake, resulting in hypernatremia and dehydration, a condition known as adipsic diabetes insipidus (ADI). Common etiologies include surgical clipping of anterior communicating artery aneurysms and suprasellar tumors involving the hypothalamus, particularly craniopharyngiomas [7-9]. Classic ADI is characterized by hypotonic polyuria and absent thirst despite hypernatremia. Additionally, destruction of magnocellular neurons abolishes AVP secretion in response to hypovolemic stimuli mediated by baroreceptors, such that polyuria persists even in the setting of hypovolemic hypernatremia [9]. Adipsic disorders are exceedingly rare and represent a major diagnostic and management challenge. Here, we present a case of a male patient with adipsic hypernatremia without polyuria following neurosurgery for a third-ventricle pilocytic astrocytoma and evaluate the utility of osmotic-stimulated plasma copeptin measurement for the functional assessment of AVP secretion in adipsia Case presentation This patient was initially evaluated at 12 years of age and followed by the neurosurgery and hematology teams after being diagnosed with a pilocytic astrocytoma of the third ventricle (Fig. 1). At that time, he underwent transcranial resection and presented hypernatremia of 150 mEq/L (150 mmol/L) (reference range, 135-145 mEq/L [135-145 mmol/L]) on the fifth postoperative day. Urinary specific gravity was 1.033, serum creatinine 0.55 mg/dL (48 mmol/L) (reference range, 0.70-1.30 mg/dL [61-114 mmol/L]), and glucose 102 mg/dL (5.6 mmol/L) (reference range, 70-100 mg/dL [3.9-5.5 mmol/L]). At age 15, he was referred to a pediatric endocrinology clinic for delayed pubertal development. Isolated hypogonadotropic hypogonadism was confirmed, and testosterone replacement was initiated. During follow-up, from 15 to 21 years old, he reported no polyuria or polydipsia and showed no evidence of additional anterior pituitary deficiencies or obesity. No additional laboratory or diagnostic assessment for hypernatremia was undertaken over the 6-year follow-up period. Pre- and postoperative MRI of the pilocytic astrocytoma. A (2013): Preoperative sagittal T1-weighted sequence after intravenous gadolinium administration. The small arrows indicate a hypothalamic neoplasm protruding into the third ventricle; the large arrow indicates the mammillary body. B (2025): Postoperative sagittal T1-weighted sequence after intravenous gadolinium administration. The small arrows indicate a hypothalamic lesion following tumor resection, with disruption of the posterior hypothalamus; the large arrow indicates the mammillary body. C (2025): Postoperative sagittal T1-weighted sequence without contrast enhancement. The arrow indicates a well-defined, normal neurohypophyseal bright spot. At age 21, during the transition to adult endocrinology care, he reported polyuria and nocturia but denied polydipsia, postural hypotension, diarrhea, or other intercurrent events. Recorded water balance data showed 24-hour urine volumes ranging from 895 to 2495 mL. Diagnostic assessment Laboratory testing showed hypernatremia of 158 mEq/L (158 mmol/L), creatinine levels of 1.32 mg/dL (116 mmol/L), hematocrit of 53% (reference range, 39.6-51.2%), and glucose levels of 83 mg/dL [4.6 mmol/L], suggesting mild dehydration. Further evaluation showed elevated plasma and urinary osmolalities of 317 mOsm/kg (317 mmol/kg) (reference range, 282-295 mOsm/kg [282-295 mmol/kg]) and 878 mOsm/Kg (878 mmol/kg) (reference range, 200-1200 mOsm/kg [200-1200 mmol/kg]), respectively. Once hypernatremia was detected, the patient was admitted for hydration and fluid balance. Oral water intake (2.5-3 L/day) was prescribed resulting in a serum sodium decrease from 158 mEq/L (158 mmol/L) to 133 mEq/L (133 mmol/L) within 72 hours. No polyuria was detected under either hyper or normonatremic states (Table 1). Suspicion of adipsic disorder, with subnormal thirst and vasopressin responses to osmotic stimulation but preserved baroregulated vasopressin release [10], prompted the evaluation of AVP secretion via copeptin measurements under hypovolemic hypernatremia and assessing copeptin and thirst responses to a normovolemic osmotic challenge. Accordingly, a 3% saline infusion test, a reliable osmotic stimulation test to assess thirst sensation and AVP secretion using copeptin measurement, was performed as previously described [11]. Table 1Patient 24-hour urine output and morning serum sodium levels during four consecutive days of oral hydration in the hospital wardDaySerum sodiumReference range24-hour urine output (mL) 1st day 148 mEq/L(148 mmol/L)135-145 mEq/L(135-145 mmol/L)1500 2nd day 143mEq/L(143 mmol/L)135-145 mEq/L(135-145 mmol/L)2360 3rd day 139 mEq/L(139 mmol/L)135-145 mEq/L(135-145 mmol/L)2200 4th day 133 mEq/L(133 mmol/L)135-145 mEq/L(135-145 mmol/L)2350 Patient 24-hour urine output and morning serum sodium levels during four consecutive days of oral hydration in the hospital ward Briefly, a first 250 mL bolus infusion of 3% saline was administered, and the infusion was continued at a rate of 0.15 mL per kilogram per minute. Blood samples for the measurement of plasma osmolality and sodium and plasma copeptin were obtained every 30 minutes, for 120 minutes. Linear 10 cm unmarked thirst visual scale was also assessed every 30 minutes, presenting a new scale for every assessment [12]. Plasma copeptin was measured using a commercial automated immunofluorescence assay, with a detection limit of 0.69 pmol/L. The intra-assay coefficient of variation ranged from <15% at 2 pmol/L to <4% at >50 pmol/L, while inter-assay precision ranged from <18% at 2 pmol/L to <5% at >50 pmol/L. (B.R.A.H.M.S KRYPTOR Copeptin proAVP, Thermo Scientific Biomarkers, USA). During the saline infusion test, sodium concentration rose from 139 mEq/L (139 mmol/L) to 150 mEq/L (150 mmol/L) and pOsm from 295 mOsm/kg (295 mmol/kg) to 321 mOsm/kg (321 mmol/kg), with no rise in the thirst scale (Fig. 2). Baseline and peak copeptin levels during the 3% saline infusion test were 3.1 and 3.2 pmol/L, respectively (osmotic stimulated copeptin reference range, 3.7-43.3 pmol/L), displaying subnormal osmotic response. Plasma copeptin, measured under hypovolemic hypernatremia with a serum sodium concentration of 158 mEq/L (158 mmol/L), was 4.1 pmol/L. Patient response curves to hypertonic saline infusion plotted against serum sodium concentration for copeptin (closed circles with solid line) (A) and thirst (closed triangles with solid line) (B). Shaded areas indicate the previously published normal ranges for copeptin [13] and thirst [12] during hypertonic saline infusion. Although the patient curve intersected the normal shaded range, both copeptin and thirst curves display reduced slopes in response to rising serum sodium. Treatment Because the patient did not present polyuria, suggesting a relatively preserved antidiuretic effect of AVP, management was limited to maintaining a fixed daily fluid intake of 2.5-3.0 L. Outcome and follow-up He has been followed every 3 months with measurements of serum sodium and assessment of fluid balance. Over the 2 years since diagnosis, he has remained free of polyuria and nocturia, with serum sodium values within normal to mildly hypernatremic range (mean 148 mEq/L [148 mmol/L]). Discussion Chronic hypernatremia is often overlooked in routine pediatric and adult care. In this case, hypernatremia and adipsia were not formally assessed but were likely present from the postoperative period and remained unrecognized. Defective thirst mechanisms can directly lead to hypernatremia; however, subtle symptoms and impaired thirst responses frequently delay diagnosis. Therefore, identifying at-risk patients is essential, particularly those who have undergone cranial neurosurgery near the third ventricle [14]. Classic ADI is characterized by hypotonic polyuria and absent thirst despite hypernatremia, with complete AVP deficiency and polyuria persisting even in the setting of hypovolemic hypernatremia [9, 15, 16]. In such a scenario, the diagnosis of AVP-D with adipsia is clinically apparent, and copeptin measurement may not provide significant additional diagnostic value. Rarer forms of adipsic disorder include Type A adipsia, also known as essential hypernatremia, characterized by upward resetting of the osmotic thresholds for both thirst and vasopressin release, and suppression of thirst and AVP release under water load with consequent polyuria. Type B adipsia which is characterized by subnormal thirst and AVP responses to osmotic stimuli with a decreased slope of the osmoregulatory lines for thirst and AVP release; and usually intact AVP release to hypotension, insulin-induced hypoglycemia and emesis, suggesting specific partial destruction of the osmoreceptors. Some of these patients retain the ability to concentrate urine and limit free water excretion in response to low AVP secretion during osmotic stimulation and develop hypotonic polyuria under water loading. Type C adipsia results from central damage leading to complete loss of both AVP secretion and thirst perception in response to osmotic stimulation. Despite absent osmotic regulation, a residual AVP response to hypotension may be preserved, as the supraoptic and paraventricular nuclei often remain intact. This presentation is classically observed in patients undergoing surgery for ruptured anterior communicating artery aneurysms of the circle of Willis [10]. Finally, the extremely rare Type D adipsia is described as adipsia with preserved osmoregulated AVP release [17]. In the present case, the presence of hypernatremia and preserved renal concentrating capacity and absence of polyuria clearly excluded ADI diagnosis. Thus, functional tests of thirst perception and AVP secretion, assessed by copeptin measurement, would help in the characterization of adipsic disorders. The blunted thirst and copeptin responses, reflected by the reduced slope of both curves relative to the rise in plasma sodium during hypertonic saline infusion, were consistent with Type B adipsia. The failure to reach near-maximal urine concentration (approximately 1000-1200 mOsm/kg) at a serum sodium of 158 mEq/L (150 mmol/L) aligns with the subnormal osmotically stimulated copeptin level of 3.2 pmol/mL. However, even under normovolemic conditions and hyponatremia, he did not develop polyuria. A likely mechanism underlying the absence of polyuria is that residual AVP secretion, although attenuated, remains sufficient to maintain effective urinary concentrating ability [18]. In addition, increased renal sensitivity to AVP has been described in patients with hypodipsia and hypernatremia, evidenced by exaggerated antidiuretic responses to ultralow dose vasopressin infusion [19]. Adipsic disorders are extremely rare and pose significant diagnostic and therapeutic challenges. The assessment of osmotic stimulated thirst sensation and copeptin levels, used to establish AVP secretion in the context of adipsia in our patient, contributed to better understand the pathophysiology involved in this osmoregulatory disorder. Plasma copeptin is a reliable diagnostic surrogate to evaluate AVP reserve, as plasma AVP assays are technically limited, while copeptin is a stable peptide released equimolarly with AVP [20-22]. Hypertonic saline–stimulated test for the differential diagnosis of polyuria-polydipsia syndrome, with copeptin assessment, has a 93.2% sensitivity and 100% specificity distinguishing primary polydipsia from AVP-D [23]. On the other hand, only a limited number of case reports in patients with adipsic hypernatremia have documented isolated AVP measurements [8] and, in exceptionally rare cases, copeptin levels [24]. In these reports, both hormones are typically inappropriately low relative to the corresponding degree of hypernatremia, as we clearly demonstrated in our patient regarding copeptin levels. Indeed, to the best of our knowledge, no previous studies have evaluated and functionally characterized copeptin secretion in patients with adipsia. The present case highlights the potential for re-appraisal of adipsic and water balance disorders using modern and perhaps more accurate tools such as plasma copeptin measurement, thereby advancing our understanding of these challenging conditions. Learning points Adipsic diabetes insipidus is a rare disorder characterized by hypotonic polyuria, chronic hypernatremia, and absent thirst. In this scenario, copeptin measurement may not provide a significant additional diagnostic value. Adipsic diabetes insipidus is a rare disorder characterized by hypotonic polyuria, chronic hypernatremia, and absent thirst. In this scenario, copeptin measurement may not provide a significant additional diagnostic value. Chronic hypernatremia is frequently overlooked. Subtle symptoms and impaired thirst mechanisms delay the diagnosis and contribute to under recognition. Identifying at-risk patients is essential, particularly those who have undergone cranial neurosurgery involving regions adjacent to the third ventricle. Chronic hypernatremia is frequently overlooked. Subtle symptoms and impaired thirst mechanisms delay the diagnosis and contribute to under recognition. Identifying at-risk patients is essential, particularly those who have undergone cranial neurosurgery involving regions adjacent to the third ventricle. Rare types of adipsic disorders include impaired osmotic AVP stimulation, upward resetting of the osmotic thresholds for thirst and AVP release, or an isolated loss of thirst perception. In these conditions, functional assessment of copeptin secretion serves as a reliable surrogate to evaluate AVP reserve. Rare types of adipsic disorders include impaired osmotic AVP stimulation, upward resetting of the osmotic thresholds for thirst and AVP release, or an isolated loss of thirst perception. In these conditions, functional assessment of copeptin secretion serves as a reliable surrogate to evaluate AVP reserve. Management of adipsic disorders focuses on fixed fluid regimens and overall water balance, aiming to prevent severe dysnatremia Management of adipsic disorders focuses on fixed fluid regimens and overall water balance, aiming to prevent severe dysnatremia Contributors All authors contributed significantly to the preparation and completion of this manuscript draft being accountable to all aspects of the work. P.C.L.E. was responsible for the conceptualization of the report, analysis, and interpretation of the data and the drafting of the work. B.R.A. played key role in the diagnosis and management of the patient, data acquisition, and critically reviewing manuscript content. A.C.S. was responsible for acquisition and analysis of MRI findings and critically reviewing manuscript content. M.C., L.L.K.E., and A.C.M. contributed to the work design, adding and critically reviewing important intellectual content. All authors critically reviewed and approved the final version of the manuscript. Contributor Information Paula Condé Lamparelli Elias, Department of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil. Beatriz Ristow de Assunção, Department of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil. Antonio Carlos dos Santos, Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil. Margaret de Castro, Department of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil. Lucila Leico Kagohara Elias, Department of Physiology, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil. Ayrton Custódio Moreira, Department of Internal Medicine, Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto 14049-900, Brazil. Funding No public or commercial funding. Disclosures None declared. Informed patient consent for publication Signed informed consent was obtained directly from the patient. Data availability Original data generated and analyzed for this case report are included in this published article. References Associated Data Data Availability Statement Original data generated and analyzed for this case report are included in this published article.